Oncodesign Precision Medicine: Report of the annual General Meeting of 30 May 2023

Nomination of Florence Dupré as a member of the Board of Directors Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing

Related Keywords

Rennes ,Bretagne ,France ,French ,Mathilde Bohin Alban Dufumier ,Fondation Universit ,Florence Dupr ,Philippe Genne ,Arthur Rouill ,Karine Lignel ,Vifor Pharma ,Bioalliance Pharma ,Le Figaro ,International Women Rights Day ,Committee Of The Syndicat National Des Technologies ,Expressions De France Association ,Medtronic ,Precision Medicine ,General Meeting ,Normale Sup ,Executive Committee ,Management Board ,Les Echos ,International Women ,Board Ready ,Oncodesign Precision Medicine ,Chief Executive Officer ,Bohin Alban Dufumier ,Gefallene Big Techs ,Oncodesign ,Precision ,Medicine ,Report ,Nnual ,Eneral ,Meeting ,023 ,